Cell and Gene Therapy Catapult’s Acquisition Of Benchmark Holdings plc’s Vaccine Manufacturing Facility

Travers Smith LLP has advised Benchmark Holdings plc on the sale of the business and assets relating to its vaccine manufacturing facility at Braintree, UK to…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here